HNN3.0
Register
Register
Register

Venus Roses Lab Solutions Ltd.

Company (SME)

www.venusroses-labsolutions.eu/Sofia, Bulgaria

About

VenusRoses Labsolutions (VR) is a contract R&D and manufacturing company specializing in innovative nutraceuticals, cosmeceuticals, herbal medicines, and food supplements. VR’s expertise spans novel encapsulation technologies (e.g. “micropellets in oil” for controlled release), in vitro/in vivo/in silico clinical validation of bioactive compounds (anti-aging, antioxidant, antimicrobial, anti-inflammatory), regulatory affairs & IPR, as well as safety and sustainability assessments (including environmental Life Cycle Assessment and techno-economic analysis). VR has a strong EU project track record (e.g. EXPLORA, INTEGRANO, MET-EFFECT, EthnoHERBS, EXANDAS), demonstrating its capacity in developing eco-friendly extraction, formulation, scale-up and commercialization of plant-derived products. Leveraging this expertise and experience, we have identified a set of Horizon Europe 2026–2027 topics under Cluster 1 (Health) and Cluster 6 (Food, Bioeconomy, Natural Resources, Agriculture & Environment) where VR could be a valuable consortium member or coordinator. Below we present these topics with rationale for alignment to VR’s capabilities and the potential role VR could play in each.

Representatives

European Affairs

Venus Roses Lab Solutions Ltd.

Marketplace (2)

  • Project cooperation

    Multisectoral approach to tackle NCD implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system

    Preventive health via diet/lifestyle; develops herbal supplements & nutraceuticals for metabolic health for community NCD prevention.

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    European Affairs at Venus Roses Lab Solutions Ltd.

    Brussels, Belgium

  • Project cooperation

    Scaling Up Innovation in Cardiovascular Health

    VR adds cardiometabolic products, pilot-scale production, MET-EFFECT know-how, and industry/regulatory input.

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    Author

    European Affairs at Venus Roses Lab Solutions Ltd.

    Brussels, Belgium